Kastrup Andreas, Skalej Martin, Krapf Hilmar, Nägele Thomas, Dichgans Johannes, Schulz Jörg B
Department of Neurology, University of Tübingen, Tübingen, Germany.
Cerebrovasc Dis. 2003;15(1-2):84-9. doi: 10.1159/000067134.
Evidence is accumulating that carotid angioplasty and stenting (CAS) might become an alternative to carotid endarterectomy (CEA) for the treatment of high-grade carotid artery disease (CAD). Evaluating the efficacy of this novel technique in single institutions in addition to performing further large trials can help to guide optimal patient management in everyday practice.
In this study we compared the early outcome of 100 prospectively followed patients who underwent CAS with a retrospectively reviewed group of 142 patients that underwent CEA over the same time period. Only patients who had received pre- and postsurgical evaluations by a neurologist were included. According to the criteria set forth by the large trials the occurrence of minor or major strokes, myocardial infarction and death within 30 days was analysed.
Both groups had similar age and sex distributions, as well as cerebrovascular risk factors. In the group of CAS patients 63 (63%) and in the group of CEA patients 92 (65%) had a symptomatic carotid stenosis, respectively. For symptomatic patients the overall complication rate (any stroke or death) was 6.5% (3 minor and 3 major strokes) in the surgical and 8% (2 minor strokes, 2 major strokes, and 1 death) in the non-surgical group (n.s.). For asymptomatic patients there was one minor stroke (2%) in the surgical and no stroke or death in the non-surgical group. As a frequent non-neurological complication the post-procedural course was complicated by groin hematoma requiring surgery in 3 CAS patients, and neck hematoma requiring additional surgery in 3 CEA patients.
Within our academic institution we found comparable complication rates for CAS and CEA in patients with symptomatic or asymptomatic high-grade CAD. Although these early results are promising and support the notion that CAS may become an alternative treatment option for CAD in everyday practice, the long-term efficacy of CAS has to be evaluated critically by means of further prospective studies.
越来越多的证据表明,对于治疗重度颈动脉疾病(CAD),颈动脉血管成形术和支架置入术(CAS)可能会成为颈动脉内膜切除术(CEA)的替代方案。除了开展进一步的大型试验外,评估这一新技术在单一机构中的疗效有助于指导日常临床实践中的最佳患者管理。
在本研究中,我们比较了100例接受CAS的前瞻性随访患者与同期142例接受CEA的回顾性研究患者的早期结局。仅纳入接受过神经科医生术前和术后评估的患者。根据大型试验设定的标准,分析30天内轻微或严重中风、心肌梗死和死亡的发生率。
两组患者的年龄、性别分布以及脑血管危险因素相似。CAS组63例(63%)和CEA组92例(65%)有症状性颈动脉狭窄。对于有症状的患者,手术组的总体并发症发生率(任何中风或死亡)为6.5%(3例轻微中风和3例严重中风),非手术组为8%(2例轻微中风、2例严重中风和1例死亡)(无显著性差异)。对于无症状患者,手术组有1例轻微中风(2%),非手术组无中风或死亡。作为常见的非神经并发症,3例CAS患者术后出现腹股沟血肿需要手术,3例CEA患者出现颈部血肿需要额外手术。
在我们的学术机构中,我们发现有症状或无症状的重度CAD患者中,CAS和CEA的并发症发生率相当。尽管这些早期结果很有前景,并支持CAS可能成为日常临床实践中CAD替代治疗选择的观点,但仍需通过进一步的前瞻性研究严格评估CAS的长期疗效。